XML 20 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (shares) at Jan. 31, 2023       3,263,659 31,572,826      
Beginning balance at Jan. 31, 2023 $ (146,400)     $ 3 $ 32 $ 1,183,921 $ (322) $ (1,330,034)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         1,742,989      
Vesting of restricted stock units 2       $ 2      
Issuance of common stock under employee stock purchase plan (shares)         332,303      
Issuance of common stock under employee stock purchase plan $ 3,406         3,406    
Exercise of stock options (shares) 7,638       7,638      
Exercise of stock options $ 65         65    
Stock-based compensation expense 64,808         64,808    
Other comprehensive income (loss) 142           142  
Net loss (75,569) $ (6,842) $ (68,727)         (75,569)
Ending balance (shares) at Jan. 31, 2024       3,263,659 33,655,756      
Ending balance at Jan. 31, 2024 (153,546)     $ 3 $ 34 1,252,200 (180) (1,405,603)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         2,378,046      
Vesting of restricted stock units 2       $ 2      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (116,694)      
Shares repurchased for tax withholdings on vesting of restricted stock (820)         (820)    
Issuance of common stock under employee stock purchase plan (shares)         273,340      
Issuance of common stock under employee stock purchase plan $ 1,910         1,910    
Exercise of stock options (shares) 0              
Stock-based compensation expense $ 57,632         57,632    
Other comprehensive income (loss) (489)           (489)  
Net loss (81,935) $ (6,946) $ (74,989)         (81,935)
Ending balance (shares) at Jan. 31, 2025   3,263,659 36,190,448 3,263,659 36,190,448      
Ending balance at Jan. 31, 2025 (177,246)     $ 3 $ 36 1,310,922 (669) (1,487,538)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         3,041,911      
Vesting of restricted stock units 3       $ 3      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (264,495)      
Shares repurchased for tax withholdings on vesting of restricted stock (3,245)         (3,245)    
Issuance of common stock under employee stock purchase plan (shares)         218,685      
Issuance of common stock under employee stock purchase plan $ 1,333         1,333    
Exercise of stock options (shares) 0              
Stock-based compensation expense $ 50,642         50,642    
Other comprehensive income (loss) 1,791           1,791  
Net loss (59,342) $ (4,726) $ (54,616)         (59,342)
Ending balance (shares) at Jan. 31, 2026   3,264,000 39,186,549 3,263,659 39,186,549      
Ending balance at Jan. 31, 2026 $ (186,064)     $ 3 $ 39 $ 1,359,652 $ 1,122 $ (1,546,880)